Orthofix International Announces International Launch of Contours PHP™ (Proximal Humeral Plate)

March 20, 2013

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced its launch of the Contours PHP™ (Proximal Humeral Plate) through the Company's International Orthopedic distribution network. This innovative plating system for the treatment of the proximal humeral fractures consists of anatomically contoured left and right plates with a low head profile. Contours PHP™ is designed to decrease the risk of impingement, while providing minimal invasiveness of metal content in the humeral head.

"The international launch of our Contours PHP™ highlights Orthofix's commitment to the trauma market," commented President and Chief Executive Officer Brad Mason. "With this internal fixation device, Orthofix now has a complete hardware offering, including a nail, plate, and external fixation system, for the repair of proximal humeral fractures."

The device provides enhanced stability through triangular configuration of the proximal screws, consisting of a Main Locking Screw and angulated Fine Threaded Screws. Contours PHP™ requires fewer and smaller diameter screws to be inserted in the humeral head, reducing the amount of bone stock required to be removed and thus decreasing the risk of further vascularity damage. Contours PHP™ can be easily applied as well as removed. The product launch is currently being rolled out in certain markets in Europe, the Middle East, and Africa. Additional information can be found at www.contoursphp.com.

About Orthofix:

Orthofix International N.V. is a diversified, global medical device company focused on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic markets. Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, and Texas Scottish Rite Hospital for Children. For more information about Orthofix, please visit www.orthofix.com.

Orthofix International N.V.
Mark Quick, 214-937-2924
Director of Investor Relations and Business Development

Source: Orthofix International N.V.

News Provided by Acquire Media